Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,480 | 59,640 | 63,295 | 55,676 | 72,549 |
| Marketable Securities | 335,043 | 329,462 | 190,216 | 219,178 | 215,776 |
| Receivables | 1,565 | 15,678 | 14,249 | 27,777 | 39,677 |
| Inventories | 13,016 | 11,109 | 10,754 | 10,262 | 11,250 |
| Other current assets | 7,881 | 10,063 | 4,008 | 5,427 | 5,593 |
| TOTAL | $380,985 | $425,952 | $282,522 | $318,320 | $344,845 |
| Non-Current Assets | |||||
| PPE Net | 66,642 | 65,601 | 65,553 | 67,774 | 69,852 |
| Investments And Advances | 3,493 | 0 | 0 | 0 | 0 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 865 | 817 | 519 | 504 | 681 |
| TOTAL | $147,501 | $142,919 | $142,573 | $144,779 | $147,034 |
| Total Assets | $528,486 | $568,871 | $425,095 | $463,099 | $491,879 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,951 | 2,816 | 7,118 | 2,328 | 2,349 |
| Accrued Expenses | 22,996 | 30,436 | 30,877 | 30,077 | 24,784 |
| Other current liabilities | 14,891 | 19,907 | 15,078 | 20,327 | 10,506 |
| TOTAL | $78,515 | $72,222 | $76,305 | $79,282 | $65,945 |
| Non-Current Liabilities | |||||
| Long Term Debt | 243,900 | 243,464 | 243,004 | 242,567 | 242,130 |
| Deferred Revenues | 24,192 | 14,352 | 14,101 | 16,015 | 17,240 |
| Other Non-Current Liabilities | 108,047 | 113,173 | 114,408 | 117,610 | 121,167 |
| TOTAL | $405,222 | $408,524 | $416,643 | $423,068 | $426,209 |
| Total Liabilities | $483,737 | $480,746 | $492,948 | $502,350 | $492,154 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,348 | 10,261 | 10,194 | 9,120 | 9,089 |
| Common Shares | 15 | 15 | 13 | 13 | 13 |
| Retained earnings | -2,085,115 | -2,021,010 | -1,978,811 | -1,935,587 | -1,886,984 |
| Other shareholders' equity | -1,849 | -2,363 | -1,962 | -2,019 | -1,835 |
| TOTAL | $44,749 | $88,125 | $-67,853 | $-39,251 | $-275 |
| Total Liabilities And Equity | $528,486 | $568,871 | $425,095 | $463,099 | $491,879 |